In GBM, JMJD8 was highly expressed in non-responders after chemotherapy, especially post-nitrosourea treatment, and the area under the curve (AUC) value of post-nitrosourea 16-month OS reached 0.7. This evidence concerns the gene JMJD8 and glioblastoma.